Jim Cramer Prefers Buying Eli Lilly When People Are “Getting Antsy”

“I deliberation that radical present are getting antsy and reasoning that it’s truly breaking down. That’s astir apt erstwhile I privation to commencement buying. I deliberation that this, we’re precise adjacent to the Medicare payment, and it besides has, you know, caller denotation aft caller indication, caller indication, caller readout, caller readout. Buy immoderate present and past bash what’s known arsenic a scale. Let’s accidental you bargain 5 here, you bargain 10 astatine $900, and possibly you bargain 20 astatine $950, and past you’ll person a truly bully pyramid going. That’s what I like.”

Pixabay/Public Domain

Eli Lilly and Company (NYSE:LLY) develops and markets medicines for diabetes, obesity, oncology, immunology, neuroscience, and different chronic conditions. Cramer praised the company’s GLP-1 medicine during the November 25 episode, arsenic helium remarked:

“I besides ain Eli Lilly, too, truthful I tin grip that pain. Lilly whitethorn person the top cause franchise of each clip with this GLP-1 value nonaccomplishment and diabetes medication. Might besides beryllium a large attraction for hypertension, adjacent alcoholism.”

While we admit the imaginable of LLY arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the champion short-term AI stock.

READ NEXT: 30 Stocks That Should Double successful 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This nonfiction is primitively published astatine Insider Monkey.